Skip to content
Search

Latest Stories

Everybody should get a flu vaccine, Johnson says announcing expanded flu programme

Prime Minister Boris Johnson said on Friday that everybody should get a flu vaccination to prevent the health service getting overwhelmed in winter if the coronavirus outbreak flares up.

Johnson described people opposed to vaccinations as “nuts,” as he promoted the government's expanded programme of flu jabs.

"There's all these anti-vaxxers now. They are nuts, they are nuts," he said, as he toured a medical centre in east London.

The government has widened its winter flu vaccination programme, given fears that combined with a second wave of coronavirus infections, NHS could be overwhelmed.

The vaccine will be free for the most vulnerable groups, including older people, those with underlying conditions, and younger children.

The Department of Health and Social Care aims to vaccinate more than 30 million when the programme gets under way later this year, it said in a statement.

Health Secretary Matt Hancock called it “the biggest flu vaccination programme in history, and will help protect our NHS as we head into winter.”

AIMp wants details for pharmacies

Welcoming the move, the Association of Independent Multiple Pharmacies (AIMp) said the government should immediately provide the details of the service to pharmacies.

“Community pharmacy has demonstrates that we are very capable of delivering such clinical services and we want to be trusted and empowered to deliver, not just flu but other clinical services to support the NHS and public health,” Leyla Hannbeck, chief executive of AIMp, commented.

“However, frontline pharmacy teams through the UK with less than 6 weeks to go feel in a state of suspended animation as to the detail or guidance to support procurement or delivery of the service.”

Hannbeck, however, expressed disappointment over the lack of proper recognition of the role community pharmacies play in the programme.

"We are increasingly concerned about the sector’s consistent ommitance from briefings unless prompted,” she said.

RPS says pharmacy must help deliver new flu vax programme

Responding to the Government’s announcement of a new expanded flu vaccination programme, RPS Director of Pharmacy and Member Experience Robbie Turner said: “The Government’s plan to expand the flu vaccination programme is excellent news. It will help patients, ready the NHS for the risk of a second peak of coronavirus and relieve winter pressures on A&E and emergency care.

“The seasonal flu campaign helps protect vulnerable groups from winter flu by offering free vaccinations. Flu is a potentially fatal condition and the significant expansion of the programme will protect the health of many more people.

“Pharmacists have been an integral part of the vaccination programme for several years, so it makes sense for them to help deliver this expanded programme. Pharmacies are typically open longer hours than GP surgeries and can often offer vaccinations at any time, making them a very convenient and easy way to protect the public against flu.”

Experts commissioned by the government's chief scientific officer have warned that if no action was taken now, nearly 120,000 people could die in hospitals alone in a second coronavirus outbreak.

Nikki Kanani, medical director of primary care for NHS England and Improvement, said: “GPs, nurses, community pharmacists and others will be going to great lengths this year to give this vital protection to millions more people in a safe and convenient way, so when the time comes I would urge everyone invited for a flu vaccination to get it as soon as possible.”


With Agencies

More For You

Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less